Introducing ECHO PITCH 2019: a special event where five start-ups in the cardiovascular health sector will compete live for up to $250,000 before a panel of judges. All are welcome to register and be part of the live audience! WHEN: Thursday Oct. 3, 2019, 3 PM to 7:30 PM WHERE: JLABS @ Toronto - 661 […]

Toronto General Hospital Research Institute (TGHRI) is happy to announce that this year’s Research Day will be held on Wednesday October 9th, 2019 at the DoubleTree by Hilton Toronto Downtown, 108 Chestnut St, Toronto, ON. This year's keynote speaker will be: Dr. Kang Lee, Professor, and Tier 1 CRC Chair in developmental neuroscience at the University of Toronto […]

The 2019 Canadian Cardiovascular Congress The 2019 Canadian Cardiovascular Congress (CCC) is being held at the Palais des congrès de Montréal in Montréal, Québec from Thursday, October 24 to Sunday, October 27. 2019 will be the inaugural year the CCC will be adjusting our program to run Thursday to Sunday. Please check the CCC website for more […]

The Till & McCulloch Meetings are Canada's stem cell research conference. As the only conference of its kind in Canada, the Till & McCulloch Meetings provide an unparalleled opportunity for you or your organization to meet and network with Canada's leading stem cell scientists, clinicians, bioengineers and ethicists, as well as representatives from industry, government, […]

Role of integrin alpha11beta1 in fibrotic disease The Gullberg laboratory has characterized the integrin α11β1, which is expressed on subsets of normal fibroblasts and on carcinoma-associated fibroblasts.

The Faculty of Dentistry at University of Toronto are hosting weekly research seminar series. The next seminar will be held on November 11, 12:30 - 1:30 pm at Faculty of Dentistry, Room 170. Dr. Ren-Ke Li will be presenting on the following topic, Novel Conductive Biomaterial Strategy for Cardiac Repair. Please see attached flyer for […]

Few technologies have the potential to disrupt and eliminate infectious disease and viral infections– but gene editing, CRISPR in particular, is a latent technology that could change biotech – and we’re just seeing the beginning of what effect it could have on the world. With scientific promise comes interest from investors – a surge of […]

The Medicine by Design Global Speaker Series invites established and emerging international leaders in regenerative medicine to engage with our extraordinary community of researchers and clinicians. Medicine by Design, in partnership with the Ontario Institute for Regenerative Medicine, is pleased to welcome James Wells, PhD, director for research, Division of Endocrinology, and chief scientific officer, Center for Stem Cell and […]